Virtual Dietary Education for Childhood Obesity in Cancer

A Bilingual Virtually-based Intervention (PEDALL) for the Prevention of Weight Gain in Childhood ALL Patients Considering Key Genetic and Sociodemographic Risk Factors

Recruiting N/A Interventional Study
Acute Lymphoblastic Leukemia Obesity
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
5 – 21
Sex
Any
Study type
Interventional
Purpose
Prevention
Participants needed
376 (estimated)
Sponsor
Columbia University · Other
Who this trial is looking for

This trial is looking for children and young adults who are receiving treatment for leukemia. Participants will take part in a six-month online program to help prevent weight gain during their cancer treatment.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am between 5 and 21 years old.
  • I have been diagnosed with acute lymphoblastic leukemia.
  • I can start the program during the first month of my maintenance therapy.
  • I speak English or Spanish fluently.
  • I have a healthy weight based on my age.
  • I am Hispanic or non-Hispanic of any race.

You may not be able to join if

  • I am on nutrition support.
  • I have a history of an eating disorder.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial

The purpose of this study is determine the effectiveness of a six-month virtually-delivered dietary education intervention (PEDALL) on the prevention of overweight and obesity (OW/OB) during maintenance chemotherapy in children and adolescents with acute lymphoblastic leukemia (ALL).

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age: 5-21 years old at enrollment * Diagnosis and Treatment: Plan to receive or are receiving maintenance or continuation chemotherapy for B- or T-cell ALL, or mixed phenotype acute leukemia. * Timing: Patient is eligible for entry only if it is feasible to start the study int…
Contacts

Pooja Vyas, MPH

2123052631

psv2103@cumc.columbia.edu

CONTACT

Elena J. Ladas, PhD, RD

212-305-7835

ejd14@cumc.columbia.edu

CONTACT